Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Melanoma: Genomic Profiles, Molecular Markers and Therapeutic Implications

NCT05119829 is registered in ClinicalTrials.gov with Hellenic Cooperative Oncology Group as lead sponsor.

NCT NCT05119829
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05119829 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Melanoma: Genomic Profiles, Molecular Markers and Therapeutic Implications
Lead sponsor
Hellenic Cooperative Oncology Group
Phase
Observational
Overall status
Unknown status
Start date
February 1, 1998
Completion date
December 31, 2023
Enrollment
80 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

melanoma